Clinical trial
Multimodal Educative Data Feedback for Deprescribing Benzodiazepine (BZD) and Related Drugs in Outpatients: a Cluster Randomized Controlled Study
NCT05859555 is registered in ClinicalTrials.gov with Réseau de soins Delta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multimodal Educative Data Feedback for Deprescribing Benzodiazepine (BZD) and Related Drugs in Outpatients: a Cluster Randomized Controlled Study
- Lead sponsor
- Réseau de soins Delta
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 5, 2022
- Completion date
- June 21, 2024
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
benzodiazepine (bzd) and related drugs, deprescription